Key Stats for DuPont De Nemours Stock
- Price change for DuPont De Nemours stock: 191%
- $DD Share Price as of Jun. 23: $140
- 52-Week High: $250
- $DD Stock Price Target: $170
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Two notable announcements put DuPont de Nemours (DD) stock in focus this week. The stock rose 191% during the day on Tuesday, but then fell 67% in pre-market trading on Wednesday.
First, the company’s Board of Directors approved a 1-for-3 reverse stock split, effective June 24, 2026. That means every three shares will be combined into one. The share count shrinks, the price per share rises, but the total value held by investors stays the same.
Second, DuPont announced that its 12 U.S.-based healthcare manufacturing facilities have fully transitioned to renewable electricity.
The company is using Renewable Energy Certificates covering roughly 30,000 megawatt-hours of annual consumption.
It’s part of DuPont’s broader 2035 sustainability goals, which focus on sustainable innovation, resilient operations, and reducing its environmental footprint.
Neither announcement is a direct earnings driver, but both reflect the direction the company is heading.
See analysts’ growth forecasts and price targets for DuPont De Nemours stock (It’s free) >>>
What the Market Is Telling Us About DuPont De Nemours Stock
DuPont De Nemours stock has had a strong run. It’s down nearly 30% over the past year and up 14% year-to-date. But it still sits 44% below its 52-week high of $250.20, which gives some context to where sentiment has been.
The company’s fundamentals look solid.
- DuPont posted organic sales growth of 2% in Q1 2026, with operating EBITDA margins expanding 130 basis points on a pro-forma basis.
- Healthcare was the standout, growing in the high single digits organically.
- The company also raised its full-year adjusted EPS guidance to $2.35–$2.40 per share.
Analyst views are mixed.
- RBC Capital raised its price target to $60, citing improving EBITDA expectations.
- Goldman Sachs initiated coverage with a Neutral rating, citing the Healthcare & Water Technologies segment as the key growth engine — one that already carries higher margins than the company average.
With a P/E ratio of 147, DuPont De Nemours stock trades at a premium. A possible overvaluation as well.
The reverse split and renewable energy transition are corporate housekeeping moves. The real story for DuPont De Nemours stock is whether the healthcare-led growth strategy can justify the valuation over time.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does DuPont De Nemours Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
